| Financial Year |
March 31 2023 |
| Monetary Funds |
72,121,558.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
114,712,952.47 |
| Accounts Receivable |
405,640,673.07 |
| Advances to Suppliers |
71,850,690.88 |
| Other Receivables |
37,137,315.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
212,801,717.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,947,417.56 |
| Total Current Assets |
1,033,396,486.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,214,700.35 |
| Investment Properties |
-- |
| Fixed Assetes |
603,452,500.90 |
| Under-construction Projects |
59,125,957.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
59,751,968.62 |
| R&D expenses |
-- |
| Goodwill |
16,973,935.10 |
| Long-Term Deferred and Prepaid Expenses |
282,261.47 |
| Deferred Income Tax Assets |
21,004,961.72 |
| Other Non-Current Assets |
529,500.00 |
| Sub-Total of Non-Current Assets |
794,257,623.25 |
| Total Assets |
1,827,654,109.69 |
| Short-Term Loans |
90,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,768,428.15 |
| Accounts Payable |
287,381,532.16 |
| Accounts Received In Advance |
14,065.01 |
| Employee Compensation Payable |
3,524,661.10 |
| Taxes Payable |
1,347,701.72 |
| Interest Payable |
555,508.47 |
| Dividend Payable |
92,427.80 |
| Other payables |
52,071,536.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,426,383.49 |
| Other Current Liabilities |
150,813,643.83 |
| Sub-Total of Current Liabilities |
668,495,750.17 |
| Long-term Loans |
469,580,000.00 |
| Bonds Payable |
128,979,683.63 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,867,834.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
609,901,976.07 |
| Total Liabilities |
1,278,397,726.24 |
| Paid-In Capital(Or Share Stock) |
190,729,815.00 |
| Capital Surplus |
224,385,772.18 |
| Surplus Reserve |
22,008,439.34 |
| LESS:Treasury Stock |
33,909,500.64 |
| Undistributed Profits |
98,340,123.39 |
| Minority Stockholder's Interest |
10,829,701.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
538,426,682.18 |
| Owner's Equity（Stockholder's Equity） |
549,256,383.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,827,654,109.69 |
